phs000007.v30.p11 Framingham Cohort | Versions 1-30: passed embargo
| VDAS | 15154 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240
|
phs000280.v5.p1 Atherosclerosis Risk in Communities (ARIC) Cohort | Versions 1-5: passed embargo
| VDAS | 15678 | Longitudinal, Cohort | | |
phs000285.v3.p2 CARDIA Cohort | Versions 1-3: passed embargo
| VDAS | 3622 | Longitudinal | Links | |
phs000090.v4.p1 GENEVA: The Atherosclerosis Risk in Communities (ARIC) Study | Versions 1-4: passed embargo
| VDAS | 12771 | Case-Control | | AFFY_6.0
|
phs000742.v1.p1 The Epilepsy Phenome/Genome Project | Version 1: passed embargo
| VDAS | 5538 | Parent-Offspring Trios, Parent-Offspring | Links | |
phs000342.v18.p11 NHLBI Framingham SNP Health Association Resource (SHARe) | Versions 1-17: passed embargo Version 18:
| VDAS | 10315 | Longitudinal | | HuGeneFocused50K_Affy Mapping250K_Nsp Mapping250K_Sty Mapping50K_Hind240 Mapping50K_Xba240 HumanOmni5-Quad
|
phs000200.v12.p3 Women's Health Initiative | Versions 1-11: passed embargo Version 12:
| VDAS | 143213 | Partial Factorial Randomized, Double-Blind, Placebo-Controlled, Cohort, Longitudinal | Links | |
phs000209.v13.p3 Multi-Ethnic Study of Atherosclerosis (MESA) Cohort | Versions 1-13: passed embargo
| VDAS | 8296 | Longitudinal, Family | Links | |
phs000086.v3.p1 DCCT-EDIC Clinical Trial and Follow-up of Persons with Type 1 Diabetes | Versions 1-3: passed embargo
| VDAS | 1497 | Clinical Trial, Longitudinal | Links | HumanHap550v3.0 ILLUMINA_Human_1M
|
phs000363.v17.p11 NHLBI Framingham SABRe CVD | Versions 1-17: passed embargo
| VDAS | 7558 | Cohort | | GeneChip Human Exon 1.0 ST Array Custom Panel TaqMan 350 MicroRNA Custom Panels
|
phs000577.v1.p1 UCDC Longitudinal Study | Version 1: passed embargo
| VDAS | 542 | Longitudinal | Links | |
phs000309.v3.p2 The CARDIA-GENEVA Study | Versions 1-3: passed embargo
| VDAS | 1926 | Longitudinal | Links | AFFY_6.0
|
phs000228.v4.p1 HMP Core Microbiome Sampling Protocol A (HMP-A) | Versions 1-4: passed embargo
| VDAS | 300 | Population-Based Control Set | Links | 454 GS FLX Titanium 454 GS FLX Titanium
|
phs000001.v3.p1 NEI Age-Related Eye Disease Study (AREDS) | Versions 1-3: passed embargo
| VDAS | 4757 | Case-Control | Links | ILMN_Human-1 Mapping50K_Hind240 Mapping50K_Xba240
|
phs000343.v3.p1 The Genomics and Randomized Trials Network (GARNET) Vitamin Intervention Stroke Prevention (VISP) trial | Versions 1-3: passed embargo
| VDAS | 2164 | Multicenter, Randomized, Clinical Trial, Double-Blind, Controlled Trial | | HumanOmni1-Quad_v1-0_B
|
phs000287.v6.p1 Cardiovascular Health Study (CHS) Cohort | Versions 1-6: passed embargo
| VDAS | 5609 | Longitudinal | | |
phs000605.v1.p1 Multicenter International Lymphangioleiomyomatosis Efficacy of Sirolimus Trial (The MILES Trial) | Version 1: passed embargo
| VDAS | 111 | Clinical Trial, Clinical Diagnostic Testing, Randomized Controlled Clinical Trial | Links | |
phs000284.v2.p1 NHLBI Cleveland Family Study (CFS) Candidate Gene Association Resource (CARe) | Versions 1-2: passed embargo
| VDAS | 1473 | Longitudinal | Links | CVDSNP55v1_A AFFY_6.0
|
phs000592.v1.p1 Screening Protocol and Longitudinal Study of Bone Marrow Failure Syndromes and Cytopenias | Version 1: passed embargo
| VDAS | 341 | Longitudinal, Prospective | Links | |
phs000308.v1.p1 The Glaucoma Genes and Environment (GLAUGEN) Study | Version 1: passed embargo
| VDAS | 2289 | Case-Control | Links | Human660W-Quad_v1_A
|